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Abstract
Background
Most patients with hepatocellular carcinoma (HCC) have underlying liver disease, therefore,
precise preoperative evaluation of the patient’s liver function is essential for surgical deci-
sion making.
Methods
We developed a grading system incorporating only two variables, namely, the serum albu-
min level and the indocyanine green retention rate at 15 minutes (ICG R15), to assess the
preoperative liver function, based on the overall survival of 1868 patients with HCC who
underwent liver resection. We then tested the model in a European cohort (n = 70) and ana-
lyzed the predictive power for the postoperative short-term outcome.
Results
The Albumin-Indocyanine Green Evaluation (ALICE) grading system was developed in a
randomly assigned training cohort: linear predictor = 0.663 × log10ICG R15 (%)−0.0718 ×
albumin (g/L) (cut-off value: -2.20 and -1.39). This new grading system showed a predictive
power for the overall survival similar to the Child-Pugh grading system in the validation
cohort. Determination of the ALICE grade in Child-Pugh A patients allowed further stratifica-
tion of the postoperative prognosis. This result was reproducible in the European cohort.
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Determination of the ALICE grade allowed better prediction of the risk of postoperative liver
failure and mortality (ascites: grade 1, 2.1%; grade 2, 6.5%; grade 3, 16.0%; mortality:
grade 1, 0%; grade 2, 1.3%; grade 3, 5.3%) than the previously reported model based on
the presence/absence of portal hypertension.
Conclusions
This new grading system is a simple method for prediction of the postoperative long-term
and short-term outcomes.
Introduction
Most of the patients with hepatocellular carcinoma (HCC) have underlying liver disease [1].
Therefore, precise preoperative evaluation of the patient’s liver function is essential to avoid
postoperative liver failure and mortality. Many attempts have been made to develop criteria of
liver function for safe liver resection [2–5]. Portal hypertension (PH) is listed as a contraindica-
tion for liver resection in Western countries, and the indocyanine green (ICG) test is widely
used in East Asian countries to decide whether patients with HCC are candidates for surgery
[6–13].
As a result of recent advances in surgical techniques and perioperative management, liver
resection has become safer, and aggressive surgical resection for HCC has been proposed [14–
18]. Therefore, the surgical strategy for HCC patients needs to be selected based on more
sensitive and accurate criteria than the Child-Pugh score, model for end-stage liver disease
(MELD) score, liver function analysis based on ICG R15 alone, or the presence/absence of PH
[4,5,6,13].
Recently, Johnson et al. [19] proposed a new evidenced-based liver function grading system
based on the serum albumin and bilirubin levels, the so-called ALBI grading system. However,
liver resection for HCC is normally limited to patients with normal bilirubin levels [1,12].
Therefore, the usefulness of the ALBI grade in surgical candidates may be simply based on the
serum albumin level.
We hypothesized that the combination of serum albumin and ICG R15 may allow simple,
but precise evaluation of the liver function and more accurate prediction of the short- and
long-term outcomes in surgical candidates. In this study, we used the data from multi-institu-
tional international databases of patients undergoing liver resection to identify the factors that
independently influence the survival and postoperative outcomes in patients with resectable
HCC. The grades determined based on a combination of albumin and ICG R15, named the
Albumin-Indocyanine Green Evaluation (ALICE) grading system, were clearly correlated with
the survival and postoperative mortality and morbidity in patients with HCC undergoing liver
resection.
Patients and Methods
Elective liver resections for HCC carried out at major centers for the management of HCC,
including two from Japan, one from the United Kingdom, and one from Switzerland were
included in the analysis. The demographic, clinical and pathological data related to this study
were extracted and analyzed retrospectively from an anonymized, prospectively collected data-
base at each institution. No additional data were collected from the participants for this study
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other than that included in the original database. Although this study protocol was not
reviewed by an ethics committee at each of the participating institutions, the collection and reg-
istration of the original database was performed according to the regulations and with the
approval of ethics committee at each institution (The University of Tokyo, Saitama Cancer
Center, University Hospital Centre Hospitalier Universitaire Vaudois, and University College
London). The extent of hepatectomy required was evaluated according to the extent of disease
progression, the liver function status, and the general condition of the patient. The status of
disease progression and resectability were assessed by imaging studies such as contrast-
enhanced computed tomography, magnetic resonance imaging, and ultrasonography. Liver
function impairment associated with the underlying liver disease was assessed by liver bio-
chemistry tests, Child-Pugh classification, and measurement of ICG R15 [12]. The ICG R15
value was measured within 3 months before surgery. In patients who underwent portal vein
embolization, the ICG R15 value after portal vein embolization was used for the analysis. At
the European centers, portal venous pressure was also evaluated preoperatively.
Macroscopic vascular invasion was defined as tumor thrombosis in the second-order
branch and/or the first order branch of the portal vein, or major hepatic vein, according to the
Japanese staging system [20]. Survival was measured from the date of surgery to the date of
death or date of last follow-up. In the Japanese centers, PH was defined according to the criteria
proposed by the Barcelona group for patients in whom the hepatic venous pressure gradient
was not measured (ie, the presence of esophageal varices and/or a platelet count of<100,000/
μL in association with splenomegaly) [21]. The presence/absence of PH was available in 1488
Japanese Child-Pugh A patients. Postoperative complications were recorded and graded
according to the Dindo-Clavien classification [22]. Ascitic complication was defined as higher
than grade II postoperative ascites. Postoperative mortality was defined as any death during
the postoperative hospital stay or within 90 days of surgery. The causes of death were liver fail-
ure in nine patients, pulmonary complications in three patients, acute renal failure in two
patients, sudden cardiac arrest in one patient, and aggressive HCC recurrence in two patients.
Major liver resection was defined as liver resection involving more than 3 Couinaud’s
segments.
Statistical analysis
Categorical variables were analyzed using the X2 test or Fisher’s exact test, as appropriate. Con-
tinuous variables were analyzed using the Wilcoxon rank-sum test. The entire Japanese cohort
(n = 1868) was randomly divided into two groups, the training set (n = 932) and the validation
set (n = 936) stratified by the institution. To identify the prognostic factors for the future
model, a multivariable analysis was performed of the data from the training set using a Cox
proportional hazards model and the backward elimination procedure. A p-value less than 0.10
was set as the cutoff value for the elimination. The following 13 variables were examined as
potential risk factors: age (y/o), sex, Child-Pugh class, serum albumin (g/L), log10bilirubin
(μmol/L), log10ICG R15(%), presence/absence of macroscopic vascular invasion, serum alpha-
fetoprotein level (ng/mL), tumor number, tumor size (cm), presence/absence of R1/2 resection,
presence/absence of satellite nodules, and the grade of differentiation of the cancer cells. Since
the Log10(ICG R15) showed a normal distribution for the entire cohort, this parameter was
used instead of the ICG R15.
Cox regression analysis was performed on the data from the Japanese training set to establish
an equation. By splitting the linear predictor at the 25th and 90th percentiles, three survival
groups were generated. Using this classification, patients with HCC were classified as low-,
medium- or high-risk patients, corresponding to the linear predictor value in the lowest 25th
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percentile, 25th and 90th percentile, and the highest 10th percentile, respectively. The overall
survival curves were determined using the Kaplan-Meier method and compared using the log-
rank test. The discriminatory performances of the ALICE grading system, Child-Pugh grading
system and the model based on the presence/absence of PH were calculated and compared
using Harrell’s C and Somers’D statistics. All statistical analyses were 2-tailed and p-values less
than 0.05 were considered to indicate statistical significance. The SAS software, version 9.3
(SAS Institute Inc., Cary, NC), was used for developing the ALICE score, randomization,
receiver operating characteristic (ROC) curve analysis, and calculating the Harrell’s C and Som-
ers’s D scores. For other analyses, the JMP 11 software (SAS Institute Inc., Cary, NC) was used.
Results
The patient characteristics of the two Japanese institutions and the European institutions are
shown in Table 1. In the European institutions, the presence of macroscopic vascular invasion,
PH, and Child-Pugh B were considered as contraindications for surgical resection.
Multivariable Cox regression analysis carried out on the data from the Japanese training set
to determine the risk factors for the overall survival identified serum albumin (g/L) (hazard
ratio [HR] 0.95, 95% confidence interval [CI] 0.92–0.97, P< 0.001), log10ICG R15 (%) (HR
2.76, 95% CI 1.75–4.37, P< 0.001), presence/absence of macroscopic vascular invasion (HR
2.50, 95% CI 1.79–3.44, P< 0.001), presence/absence of satellite nodules (HR 1.89, 95% CI
1.45–2.44, P< 0.001), and presence/absence of R 1/2 resection (HR 2.69, 95% CI 1.86–3.79,
P< 0.001) as significant risk factors (Table 2). Of note, the log10bilirubin (μmol/L) was not
identified as a significant variable.
Table 1. Characteristics of the cohorts.
Patient characteristics Japan (Center 1) Japan (Center 2) Europe (Multicenter)
Total number of patients 1466 402 70
Accrual period 1994–2011 1989–2014 2008–2014
Age (years)* 66 (59–72) 68 (63–73) 63 (55–70)
Gender (Male/female)** 1169/297 (80/20) 316/86 (79/21) 60/10 (86/14)
Child-Pugh class (A/B) 1265/201 (86/14) 373/29 (93/7) 70/0 (100/0)
Presence of macroscopic vascular invasion 110 (7.5) 31 (7.7) 0 (0)
Serum albumin (g/L) 37 (34–40) 39 (36–42) 43 (39–45)
ICG retention rate at 15 min (%) 14.2 (9.3–20.7) 13.2 (9.5–19.4) 9.9 (5.7–15.1)
*Median (IQR),
**Number (%) IQR, interquartile range;
ICG, indocyanine green.
doi:10.1371/journal.pone.0159530.t001
Table 2. Multivariable Cox regression analysis of the data of the Japanese training cohort to identify
prognostic factors associated with the survival.
Risk factors P value Hazard ratio (95% conﬁdence interval)
Serum albumin (g/L) < 0.001 0.95 (0.92–0.97)
Log10 ICG R15 (%) < 0.001 2.76 (1.75–4.37)
Macroscopic vascular invasion < 0.001 2.50 (1.79–3.44)
Satellite nodules < 0.001 1.89 (1.45–2.44)
R1/2 resection < 0.001 2.69 (1.86–3.79)
ICG R15, indocyanine green retention rate at 15 minutes.
doi:10.1371/journal.pone.0159530.t002
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We confined our model to the serum albumin and log10ICG R15(%) to focus on the vari-
ables related to the liver function. A Cox regression equation based on only the serum albumin
and log10ICG R15(%) was built for the Japanese training set, and the equation for the linear
predictor was as follows: linear predictor = (0.663 × log10ICG R15 [%])—(0.0718 × albumin [g/
L]). Then the patients were classified into three prognostic groups, that is, ALICE grades 1 to 3
based on the values of the linear predictor, as follows; linear predictor value -2.20, ALICE
grade 1; linear predictor value -2.20 to -1.39, ALICE grade 2; linear predictor value more
than -1.39, ALICE grade 3.
The ALICE grading system was then applied to the training and validation sets of the Japa-
nese cohort and compared with the Child-Pugh grading system for the same datasets. The
Kaplan-Meier curve showed equally good discrimination between the three ALICE prognostic
groups and the two Child-Pugh grade (A/B) groups (Figs 1–4). An ROC curve analysis of the
ALICE score revealed that a universally good prediction for the whole population in the train-
ing cohort (Fig 5). The Harrell’s C and Somers’ D scores were similar, being 0.66 and 0.32 vs.
Fig 1. Overall survival according to the Albumin-Indocyanine Green Evaluation (ALICE) grade in the Japanese training cohort. Numbers
below the x-axis indicate the number of patients at risk.
doi:10.1371/journal.pone.0159530.g001
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0.65 and 0.30, in the training set, 0.64 and 0.29 vs. 0.68 and 0.35 in the validation set, respec-
tively. The median survival times (MSTs) of the ALICE grade 1, grade 2 and grade 3 patients
were 11.8 y, 5.55 y and 3.27 y in the training set, and 11.9 y, 5.71 y and 3.08 y in the validation
set, respectively. When the Child-Pugh grading system was applied, the MSTs in the Child-
Pugh class A and B patients were 6.18 y and 3.39 y in the training set, and 6.75 y and 3.48 y in
the validation set, respectively.
The new ALICE grading system was then applied to the European cohort. Since only 2
patients were classified as ALICE grade 3, we compared the overall survival between ALICE
grade 1 and grade 2 patients; the overall survival was significantly longer in the grade 1 group
as compared with that in the grade 2 group (P = 0.007), confirming the validity of the new
grading system in western populations (Fig 6).
As the presence of PH is considered to be a significant risk factor for a poor prognosis in
Child-Pugh A patients [9], we compared the ALICE grading system to the model based on the
presence/absence of PH in Child-Pugh A patients of the validation dataset. The Kaplan-Meier
curve showed that the ALICE grading system allowed better discrimination of the risk than
Fig 2. Overall survival according to the Child-Pugh grade in the Japanese training cohort.Numbers below the x-axis indicate the number of
patients at risk.
doi:10.1371/journal.pone.0159530.g002
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model based on the presence/absence of PH (Figs 7 and 8). The Harrell’s C and Somers’ D
scores were better for the ALICE grading system than for the model based on the presence/
absence of PH (0.61 and 0.23 vs. 0.54 and 0.08, respectively). The MSTs in the patients with
ALICE grade 1, grade 2 and grade 3 were 12.5 y, 6.45 y, and 3.37 y, respectively, while those in
the group with and without PH were 8.03 y and 6.03 y, respectively.
In order to analyze the predictive power of the ALICE grade for the short-term outcome, we
analyzed the postoperative outcomes according to the ALICE grade and presence/absence of
PH in the Child-Pugh A patients of the Japanese cohort (Table 3). Consistent with a previous
report [9], the group with PH showed a significantly higher rate of ascites, and therefore a
higher overall rate of complications and a longer hospital stay. The ALICE grading system also
allowed the patients to be stratified according to the risk of ascites complication, overall rate of
complications and length of hospital stay. In addition, the need for red blood cell transfusion
and the mortality rate increased significantly as the ALICE grade became worse (transfusion
requirement: grade 1, 5.0%; grade 2, 7.9%; grade 3, 14.7%; mortality rate: grade 1, 0%; grade 2,
Fig 3. Overall survival according to the Albumin-Indocyanine Green Evaluation (ALICE) grade in the Japanese validation cohort.
Numbers below the x-axis indicate the number of patients at risk.
doi:10.1371/journal.pone.0159530.g003
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Fig 4. Overall survival according to the Child-Pugh grade in the Japanese validation cohort.Numbers below the x-axis indicate the number of
patients at risk.
doi:10.1371/journal.pone.0159530.g004
Fig 5. ROC curve of Albumin-Indocyanine Green Evaluation (ALICE) score in the Japanese training
cohort.
doi:10.1371/journal.pone.0159530.g005
Assessment of Preoperative Liver Function - ALICE Grade
PLOS ONE | DOI:10.1371/journal.pone.0159530 July 19, 2016 8 / 15
1.3%; grade 3, 5.3%); such stratification was not possible in the model based on the presence/
absence of PH (Table 3).
A heat map using the 25th and 90th percentiles as the cut-off values for the ALICE grade
revealed that most of the subjects with ALICE grade 1 had normal liver function, while those
with ALICE grade 3 had poor liver function approximating Child-Pugh grade B (Fig 9). The
extent of liver resection should be carefully considered in patients with ALICE grade 2. There-
fore, we evaluated the extent of resection in ALICE grade 2 patients. We divided the patients
with ALICE grade 2 into 2 groups using the median linear predictor (-1.88) as a cut-off value.
Thus, the patients were classified into two groups (ALICE grades 2a and 2b) based on the val-
ues of the linear predictor as follows: ALICE grade 2a, linear predictor value of -2.20 to
-1.88; ALICE grade 2b, linear predictor value of more than -1.88 to -1.39. The rates of PH in
each grade were as follows: ALICE grade 1, 11.0% (48/437); ALICE grade 2a, 18.3% (88/481);
ALICE grade 2b, 29.1% (144/495); and ALICE grade 3, 45.3% (34/75). Although major resec-
tion, i.e. more than 3 Couinaud’s segments, did not affect the incidence of ascites or the mortal-
ity rate in the ALICE grade 2a group (ascites: minor resection,18/433 [4.2%]; major resection,
Fig 6. Overall survival according to the Albumin-Indocyanine Green Evaluation (ALICE) grade in the European cohort.Numbers below the
x-axis indicate the number of patients at risk.
doi:10.1371/journal.pone.0159530.g006
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2/48 [4.2%]; mortality rate: minor resection, 4/433 [0.9%]; major resection, 1/48 [2.1%]), major
resection in the ALICE grade 2b group had a significantly higher incidence of ascites and mor-
tality rate (ascites: minor resection, 33/442 [7.5%]; major resection, 10/53 [18.9%]; mortality
rate: minor resection, 5/442 [1.1%]; major resection, 3/53 [5.7%]), similar to the results for
patients with ALICE grade 3 (Fig 10).
Discussion
The current study revealed that the new simple evidence-based model incorporating the serum
albumin level and ICGR15 could be at least as useful for predicting the long-term outcome in
HCC patients undergoing liver resection as the Child-Pugh grade. This new grading system
was also useful for further stratification of Child-Pugh A patients. In addition, the ALICE
grade was a better predictor of the postoperative long-term and short-term outcomes than the
risk class based on the presence/absence of PH. Major liver resection among ALICE grade 2b
patients was correlated with significantly higher morbidity and mortality rates.
Fig 7. Overall survival according to the Albumin-Indocyanine Green Evaluation (ALICE) grade in a Japanese Child-Pugh A validation
cohort. Numbers below the x-axis indicate the number of patients at risk.
doi:10.1371/journal.pone.0159530.g007
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Fig 8. Overall survival based on the presence/absence of portal hypertension (PH) in a Japanese Child-Pugh A validation cohort.Numbers
below the x-axis indicate the number of patients at risk.
doi:10.1371/journal.pone.0159530.g008
Table 3. Postoperative outcomes according to the Albumin-Indocyanine Green Evaluation (ALICE) grade and presence/absence of portal hyper-
tension in the Child-Pugh A patients of the entire Japanese cohort.
ALICE grade
1n = 437
ALICE grade
2n = 976
ALICE grade
3n = 75
P values (2 vs.
3)
non-PH
groupn = 1174
PH
groupn = 314
P values
Operative time (min)* 320 (245–414) 340 (265–450) 335 (260–510) P = 0.509 340 (260–435) 340 (255–460) P = 0.341
Blood loss (ml) 530 (280–900) 670 (380–1128) 810 (380–1490) P = 0.076 600 (330–1052) 684 (428–1320) P < 0.001
RBC transfusion
required**
22 (5.0) 77 (7.9) 11 (14.7) P = 0.041 88 (7.5) 22 (7.0) P = 0.769
Median hospital stay
(d)
14 (11–17) 16 (13–21) 20 (14–26) P = 0.010 15 (12–19) 17 (14–24) P < 0.001
Presence of
complication
72 (16.5) 232 (23.8) 28 (37.3) P = 0.009 248 (21.1) 84 (26.8) P = 0.033
Ascites 9 (2.1) 63 (6.5) 12 (16.0) P = 0.002 54 (4.6) 30 (9.6) P < 0.001
90-day mortality 0 (0) 13 (1.3) 4 (5.3) P = 0.008 15 (1.3) 2 (0.6) P = 0.343
*Median (IQR),
**Number (%) IQR, interquartile range;
RBC, red blood cells; PH, portal hypertension.
doi:10.1371/journal.pone.0159530.t003
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The proposed surgical strategies for HCC patients according to the ALICE grade are shown
in Fig 11. Since ALICE grade 3 was associated with a poor prognosis and a high risk of postop-
erative liver failure, surgical resection in subjects classified as ALICE 3 should be considered
carefully. The extent of liver resection should be limited in ALICE grade 3 patients, and abla-
tion therapy or liver transplantation could be suitable alternatives where the tumor status is
appropriate. In the patients with ALICE grade 1, since the risk of postoperative liver failure is
extremely low and the MST is more than 10 years, surgical resection rather than liver trans-
plantation is recommended. Patients in this group can be considered as having normal liver
function and aggressive surgery such as trisectionectomy can be attempted. Since liver function
is impaired in patients with ALICE grade 2, the extent of liver resection should be limited to 4
Couinaud’s segments, such as a right hepatectomy or an extended left hepatectomy. Since
major resection was associated with high morbidity and mortality rates in ALICE grade 2b
patients, liver resection should preferably be limited to 3 Couinaud’s segments, such as a left
hepatectomy or sectionectomy.
Fig 9. Heat map showing the Albumin-Indocyanine Green Evaluation (ALICE) grade. ALICE grade 1: green, ALICE grade 2a: yellow a,
ALICE grade 2b: yellow b, ALICE grade 3: red.
doi:10.1371/journal.pone.0159530.g009
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As compared to the ALBI grade, in our data, the serum bilirubin level showed no significant
association with the postoperative survival. This could be attributable to the fact that liver
resection was confined to patients with normal serum bilirubin levels. However, Johnson et al.
[19] demonstrated the effectiveness of the ALBI grade in predicting the postoperative survival
in HCC patients undergoing liver resection. This is probably due to the effect of the serum
albumin level, and indeed, the ALBI grade was also effective in our study population (data not
shown). These results indicate that the serum albumin level is a strong predictor of the liver
function.
Evaluation for the presence or absence of PH has been proposed in western countries, while
measurement of the ICG R15 has been proposed in eastern countries [1]. This study clearly
demonstrated that ALICE grading is superior to classification based on the presence/absence
of PH for stratification of the prognosis and prediction of postoperative liver failure. The algo-
rithm based on the ALICE grade modified the criteria proposed by Makuuchi et al. [12,13] by
adding albumin, which is considered to be the most important variable influencing the Child-
Pugh grade or the ALBI grade in HCC patients undergoing surgical resection. Therefore the
Fig 10. Incidence of ascites andmortality rate according to the Albumin-Indocyanine Green Evaluation (ALICE) grade.
doi:10.1371/journal.pone.0159530.g010
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ALICE grade can be considered as a combination of the Makuuchi criteria and the Child-Pugh
grading system.
One of the limitations of this study was its retrospective nature. Since the extent of liver
resection was based on the ICG R15 value and the Makuuchi criteria in the Japanese cohort,
this may have caused a significant bias in our results. Although we confirmed the usefulness of
ALICE grading in western populations, the population size of the western cohort was relatively
small, because ICG R15 is not routinely measured in most western countries. Furthermore, dif-
ferences in ethnicity may be one of the reasons that PH only had small impact on postoperative
survival and the rate of complications. Therefore, these findings need to be confirmed in a pro-
spective study carried out in a large number of western subjects.
In conclusion, this new grading system based on the serum albumin and ICG R15 is a sim-
ple and objective system that is useful for predicting the postoperative long-term and short-
term outcomes after surgical resection for HCC. This new system could be potentially used
worldwide for surgical decision making in patients with HCC.
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